Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Spodoptera frugiperda | Ecdysone receptor | Starlite/ChEMBL | No references |
Spodoptera littoralis | Ecdysone receptor | Starlite/ChEMBL | References |
Bombyx mori | Ecdysone receptor | Starlite/ChEMBL | References |
Drosophila melanogaster | ultraspiracle | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Onchocerca volvulus | Bile acid receptor homolog | Get druggable targets OG5_134445 | All targets in OG5_134445 |
Brugia malayi | ecdysteroid receptor | Get druggable targets OG5_134445 | All targets in OG5_134445 |
Echinococcus granulosus | retinoic acid receptor rxr beta a | Get druggable targets OG5_130073 | All targets in OG5_130073 |
Schistosoma japonicum | ko:K08524 nuclear receptor, subfamily 2, group B, member 1, putative | Get druggable targets OG5_130073 | All targets in OG5_130073 |
Schistosoma mansoni | retinoic acid receptor RXR | Get druggable targets OG5_130073 | All targets in OG5_130073 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_134445 | All targets in OG5_134445 |
Echinococcus multilocularis | retinoic acid receptor rxr beta a retinoic acid receptor rxr alpha a retinoic acid receptor rxr alpha | Get druggable targets OG5_130073 | All targets in OG5_130073 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus multilocularis | ecdysone induced protein 78C | Ecdysone receptor | 585 aa | 476 aa | 25.0 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | retinoic acid receptor rxr beta a | 0.0208 | 0.2857 | 1 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.0208 | 0.2857 | 1 |
Echinococcus multilocularis | retinoic acid receptor rxr beta a retinoic acid receptor rxr alpha a retinoic acid receptor rxr alpha | 0.0182 | 0.2393 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0604 | 1 | 1 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0604 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | = 5.01 | Agonist activity at ecdysone receptor in Drosophila melanogaster S2 cells after 24 hr by luciferase reporter gene assay | ChEMBL. | 20672340 |
EC50 (binding) | = 7.13 | Agonist activity at ecdysone receptor in Spodoptera littoralis Sl2 cells after 24 hr by luciferase reporter gene assay | ChEMBL. | 20069627 |
EC50 (binding) | = 7.51 | Agonist activity at ecdysone receptor in Bombyx mori Bm5 cells after 24 hr by luciferase reporter gene assay | ChEMBL. | 20069627 |
EC50 (binding) | = 8.04 | Agonist activity at ecdysone receptor in Bombyx mori Bm5 cells after 24 hr by luciferase reporter gene assay | ChEMBL. | 20672340 |
Efficacy (binding) | = 52 % | Agonist activity at ecdysone receptor in Drosophila melanogaster S2 cells at 10 uM after 24 hr by luciferase reporter gene assay relative to 20-hydroxyecdysone | ChEMBL. | 20672340 |
Efficacy (binding) | = 75 % | Agonist activity at ecdysone receptor in Spodoptera littoralis Sl2 cells after 24 hr by luciferase reporter gene assay relative to tebufenozide | ChEMBL. | 20069627 |
Efficacy (binding) | = 107 % | Agonist activity at ecdysone receptor in Bombyx mori Bm5 cells after 24 hr by luciferase reporter gene assay relative to tebufenozide | ChEMBL. | 20069627 |
IC50 (binding) | = 7.64 | Displacement of [3H]PonA from ecdysone receptor in Spodoptera frugiperda (fall armyworm) Sf-9 cells after 30 min by liquid scintillation counting | ChEMBL. | No reference |
Inhibition (binding) | = 48.7 % | Inhibition of human P-glycoprotein transfected in pig LLC-GA5-COL150 cells assessed as quinidine transport from apical to basolateral side at 30 uM preincubated for 30 mins followed by quinidine addition to apical side measured after 60 mins | ChEMBL. | 27262425 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.